Northwest Bank & Trust’s Amgen AMGN Stock Holding History

Northwest Bank & Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$576K	–	193
2023 Q4	$576K	Buy	+2,000	New	+$545K	0.52%	61
2023 Q2	$444K	Buy	+2,000	New	+$464K	0.43%	62

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northwest Bank & Trust's AMGN Position: Q1 2024 in Review

Northwest Bank & Trust sold out of Amgen (AMGN) in Q1 2024, closing a stake of 2,000 shares — an estimated $576K sold.

Northwest Bank & Trust first reported a position in AMGN in Q2 2023 and held it in 2 quarters. The position peaked at $576K in Q4 2023. 2,721 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

Northwest Bank & Trust reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
Northwest Bank & Trust sold 2,000 Amgen shares in Q1 2024, an estimated $576K.
Northwest Bank & Trust first reported a position in Amgen in Q2 2023 and held it in 2 quarters.
Northwest Bank & Trust's Amgen position peaked at $576K in Q4 2023.
2,721 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Northwest Bank & Trust's 13F filing for Q1 2024, filed 24 May 2024.